Unveiling Cardiac Amyloidosis, its Characteristics, and Outcomes Among Patients With MR Undergoing Transcatheter Edge-to-Edge MV Repair
Cardiac Amyloidosis
Concomitant
AL amyloidosis
DOI:
10.1016/j.jcin.2022.06.009
Publication Date:
2022-08-22T07:01:46Z
AUTHORS (26)
ABSTRACT
Mitral regurgitation (MR) and cardiac amyloidosis (CA) both primarily affect older patients. Data on coexistence prognostic implications of MR CA are currently lacking. This study sought to identify the prevalence, clinical characteristics, outcomes compared with lone MR. Consecutive patients undergoing transcatheter edge-to-edge repair (TEER) for at 2 sites were screened concomitant using a multiparametric approach including core laboratory 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid bone scintigraphy echocardiography immunoglobulin light chain assessment. Transthyretin (ATTR) was diagnosed by (Perugini grade 1: early infiltration; grades 2/3: CA) absence monoclonal protein, (AL) via tissue biopsy. All-cause mortality hospitalization heart failure (HHF) served as endpoints. A total 120 (age 76.9 ± 8.1 years, 55.8% male) recruited. Clinical in 14 (11.7%; 12 ATTR, 1 AL, combined ATTR/AL) amyloid infiltration 9 (7.5%). Independent predictors increased posterior wall thickness presence left anterior fascicular block electrocardiography. Procedural success periprocedural complications TEER similar (P all = NS). After median 1.7 25.8% had experienced death and/or HHF. worse (HR: 2.2; 95% CI: 1.0-4.7; P 0.034), driven 2.5-fold higher risk HHF 2.5; 1.1-5.9), but comparable 1.6; 0.4-6.1). Dual pathology is common elderly has postinterventional
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (15)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....